India
· Delayed Price · Currency is INR Caplin Point Laboratories Statistics
Total Valuation
Caplin Point Laboratories has a market cap or net worth of INR 149.36 billion. The enterprise value is 142.18 billion.
| Market Cap | 149.36B |
| Enterprise Value | 142.18B |
Important Dates
The last earnings date was Thursday, November 7, 2024.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | Sep 23, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.10% |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 19.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.52, with an EV/FCF ratio of 61.55.
| EV / Earnings | 28.81 |
| EV / Sales | 7.76 |
| EV / EBITDA | 23.52 |
| EV / EBIT | 26.14 |
| EV / FCF | 61.55 |
Financial Position
The company has a current ratio of 6.07, with a Debt / Equity ratio of 0.00.
| Current Ratio | 6.07 |
| Quick Ratio | 4.53 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.00 |
| Debt / FCF | 0.01 |
| Interest Coverage | 937.91 |
Financial Efficiency
Return on equity (ROE) is 21.24% and return on invested capital (ROIC) is 14.52%.
| Return on Equity (ROE) | 21.24% |
| Return on Assets (ROA) | 12.74% |
| Return on Capital (ROIC) | 14.52% |
| Revenue Per Employee | 5.38M |
| Profits Per Employee | 1.45M |
| Employee Count | 3,406 |
| Asset Turnover | 0.69 |
| Inventory Turnover | 2.37 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +56.96% in the last 52 weeks. The beta is 0.41, so Caplin Point Laboratories's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | +56.96% |
| 50-Day Moving Average | 1,945.56 |
| 200-Day Moving Average | 1,579.53 |
| Relative Strength Index (RSI) | 50.39 |
| Average Volume (20 Days) | 108,052 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Caplin Point Laboratories had revenue of INR 18.33 billion and earned 4.94 billion in profits. Earnings per share was 64.65.
| Revenue | 18.33B |
| Gross Profit | 10.45B |
| Operating Income | 5.44B |
| Pretax Income | 6.14B |
| Net Income | 4.94B |
| EBITDA | 6.03B |
| EBIT | 5.44B |
| Earnings Per Share (EPS) | 64.65 |
Balance Sheet
The company has 8.27 billion in cash and 24.30 million in debt, giving a net cash position of 8.24 billion.
| Cash & Cash Equivalents | 8.27B |
| Total Debt | 24.30M |
| Net Cash | 8.24B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 25.75B |
| Book Value Per Share | 324.91 |
| Working Capital | 16.69B |
Cash Flow
In the last 12 months, operating cash flow was 3.75 billion and capital expenditures -1.44 billion, giving a free cash flow of 2.31 billion.
| Operating Cash Flow | 3.75B |
| Capital Expenditures | -1.44B |
| Free Cash Flow | 2.31B |
| FCF Per Share | n/a |
Margins
Gross margin is 57.02%, with operating and profit margins of 29.68% and 26.93%.
| Gross Margin | 57.02% |
| Operating Margin | 29.68% |
| Pretax Margin | 33.52% |
| Profit Margin | 26.93% |
| EBITDA Margin | 32.92% |
| EBIT Margin | 29.68% |
| FCF Margin | 12.60% |
Dividends & Yields
Caplin Point Laboratories does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | 11.11% |
| Years of Dividend Growth | 10 |
| Payout Ratio | 7.69% |
| Buyback Yield | 0.10% |
| Shareholder Yield | 0.10% |
| Earnings Yield | 3.29% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on October 19, 2016. It was a forward split with a ratio of 5.
| Last Split Date | Oct 19, 2016 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |